Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

Authors: Kevan C. Herold, Stephen E. Gitelman, Steven M. Willi, Peter A. Gottlieb, Frank Waldron-Lynch, Lesley Devine, Jennifer L. Sherr, S. M. Rosenthal, S. Adi, Muhammad Yazid Jalaludin, Aaron W. Michels, J. Dziura, Jeffrey A. Bluestone - Diabetologia 2012 cited by 157